Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2011
| Drug Name | Review Type | Class | Manufacturer |
|---|---|---|---|
| Incivek | New Drug Initial Review | Hepatitis C | Vertex |
| Victrelis | New Drug Initial Review | Hepatitis C | Merck |
| Natroba | New Drug Initial Review | Pediculicide | ParaPRO |
| Xarelto | New Drug Initial Review | Factor Xa Inhibitor | Johnson & Johnson |
| Tradjenta | New Drug Initial Review | DPP-4 Inhibitor | Boehringer-Ingelheim |
| Moxeza | New Drug Initial Review | Ophthalmic - Antibiotic | Alcon |